DAVID CORRY to Drug Evaluation, Preclinical
This is a "connection" page, showing publications DAVID CORRY has written about Drug Evaluation, Preclinical.
Connection Strength
0.061
-
Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease. J Biol Chem. 2018 06 29; 293(26):10026-10040.
Score: 0.035
-
Agonistic induction of PPAR? reverses cigarette smoke-induced emphysema. J Clin Invest. 2014 Mar; 124(3):1371-81.
Score: 0.026